Citations for
1HILPDA
Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer.
Nishimura S, Tsuda H, Nomura H, Kataoka F, Chiyoda T, Tanaka H, Tanaka K, Susumu N, Aoki D.
Eur J Gynaecol Oncol 32(2):146-9. 2011
2DBN1, HILPDA, SETMAR, SOX11
Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
Wang X, Björklund S, Wasik AM, Grandien A, Andersson P, Kimby E, Dahlman-Wright K, Zhao C, Christensson B, Sander B.
PLoS One 5(11):e14085. 2010
3HILPDA
Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1.
Gimm T, Wiese M, Teschemacher B, Deggerich A, Schödel J, Knaup KX, Hackenbeck T, Hellerbrand C, Amann K, Wiesener MS, Höning S, Eckardt KU, Warnecke C.
FASEB J 24(11):4443-58. Epub 2010 Jul 12. 2010
4HILPDA
Differential expression of hypoxia-inducible protein 2 among different histological types of epithelial ovarian cancer and in clear cell adenocarcinomas.
Nishimura S, Tsuda H, Ito K, Takano M, Terai Y, Jobo T, Kigawa J, Sugiyama T, Yaegashi N, Aoki D.
Int J Gynecol Cancer 20(2):220-6. 2010
5HILPDA
Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy.
Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, Sakamoto Y, Fujime M, Kawachi Y, Shuin T, Nakamura Y.
Cancer Res 65(11):4817-26. 2005
6HILPDA
Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment.
Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A.
Clin Cancer Res 6(2):480-7. 2000